pI: 9.0302 |
Length (AA): 302 |
MW (Da): 32797 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 3
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 2 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
195 | 251 | 5h8z (A) | 196 | 259 | 32.00 | 0 | 0.01 | 0.177242 | 1.86 |
268 | 297 | 4c9j (A) | 75 | 104 | 30.00 | 0.71 | 0.03 | 0.104538 | 2.79 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Ortholog group members (OG5_129029)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT2G33820 | mitochondrial ornithine transporter |
Brugia malayi | Bm1_17435 | Mitochondrial carrier protein |
Candida albicans | CaO19.5926 | potential mitochondrial carrier protein similar to S. cerevisiae ORT1 (YOR130C) ornithine transporter |
Candida albicans | CaO19.13347 | potential mitochondrial carrier protein similar to S. cerevisiae ORT1 (YOR130C) ornithine transporter |
Caenorhabditis elegans | CELE_T10F2.2 | Protein T10F2.2 |
Drosophila melanogaster | Dmel_CG1628 | CG1628 gene product from transcript CG1628-RC |
Homo sapiens | ENSG00000120329 | solute carrier family 25 (mitochondrial carrier |
Homo sapiens | 10166 | solute carrier family 25 (mitochondrial carrier |
Leishmania braziliensis | LbrM.25.0210 | mitochondrial carrier protein, putative |
Leishmania donovani | LdBPK_250210.1 | mitochondrial carrier protein, putative |
Leishmania infantum | LinJ.25.0210 | mitochondrial carrier protein, putative |
Leishmania major | LmjF.25.0210 | mitochondrial carrier protein, putative |
Leishmania mexicana | LmxM.25.0210 | mitochondrial carrier protein, putative |
Loa Loa (eye worm) | LOAG_04855 | carrier protein |
Mus musculus | ENSMUSG00000031482 | solute carrier family 25 (mitochondrial carrier ornithine transporter), member 15 |
Oryza sativa | 9267032 | Os11g0423800 |
Saccharomyces cerevisiae | YOR130C | Ort1p |
Schistosoma japonicum | Sjp_0202340 | Mitochondrial ornithine transporter 1, putative |
Schistosoma mansoni | Smp_000680 | ornithine transporter 2 (solute carrier family 25 member 2) |
Schmidtea mediterranea | mk4.001170.03 | Ornithine transporter 2 |
Trypanosoma brucei gambiense | Tbg972.11.150 | mitochondrial carrier protein, putative |
Trypanosoma brucei | Tb927.11.270 | mitochondrial carrier protein |
Trypanosoma congolense | TcIL3000.11.180 | mitochondrial carrier protein, putative |
Trypanosoma cruzi | TcCLB.504109.70 | mitochondrial carrier protein, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb11.03.0870 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb11.03.0870 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb11.03.0870 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb11.03.0870 | Trypanosoma brucei | significant gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.